Does fish oil benefit stone formers?
The possibility that dietary fish oil supplementation may benefit patients with hypercalciuric urolithiasis by decreasing calcium excretion and enhancing protective mechanisms has been studied in rats and humans. In experiments on rats in metabolic cages, fish oil inhibited experimental nephrocalcinosis induced by intraperitoneal calcium gluconate. There were no significant changes in urinary biochemistry. In a clinical study on 18 hypercalciuric recurrent stone patients fish oil significantly decreased urinary calcium excretion. This effect was accompanied by decreases in the excretion of magnesium and citrate. Oxalate excretion and urinary fibrinolytic activity were unchanged. Overall, fish oil had a limited impact on the risk profile for recurrent urolithiasis.
Rothwell
P J
PJ
Department of Urology, University Hospital of South Manchester, United Kingdom.
Green
R
R
Blacklock
N J
NJ
Kavanagh
J P
JP
D000328:Adult; D000368:Aged; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004042:Dietary Fats, Unsaturated / Q000378:metabolism; D005395:Fish Oils / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069463:Olive Oil; D010938:Plant Oils / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012008:Recurrence; D014545:Urinary Calculi / Q000378:metabolism / Q000517:prevention & control*
D004042:Dietary Fats, Unsaturated; D005395:Fish Oils; D000069463:Olive Oil; D010938:Plant Oils; D002118:Calcium